Expression of a constitutively activated version of the heterotrimeric G protein α-subunit Gα s results in the swelling and vacuolization of a specific subset of ventral nerve cord motoneurons of Caenorhabditis elegans. A second site modifier (sgs-1) that completely suppresses this neuronal degeneration has been isolated. sgs-1 was cloned and was shown to encode an adenylyl cyclase which is most similar to mammalian adenylyl cyclase type IX. Mutations in sgs-1 change residues that are conserved among different adenylyl cyclases. These mutations are located in the two catalytic domains and in the first multiple transmembrane spanning region of the predicted protein. An sgs-1 reporter construct shows a general neuronal expression pattern, demonstrating that sgs-1 is expressed in the neurons that are susceptible to activated Gα s -induced cell death. A second C.elegans adenylyl cyclase gene (acy-2) was analyzed as well. In contrast to sgs-1, acy-2 shows a restricted expression pattern and loss of acy-2 function results in early larval lethality. These results suggest that SGS-1 is a target of Gα s signaling in motoneurons, whereas an interaction of Gα s with ACY-2, probably in the canal-associated neurons, is required for viability.
Introduction
Heterotrimeric G proteins connect serpentine transmembrane receptors to a variety of intracellular effectors. G proteins consist of a guanine nucleotide binding α-subunit and a βγ-subunit, both of which have signaling capabilities (Kaziro et al., 1991; Simon et al., 1991) . The nematode Caenorhabditis elegans expresses homologs of a number of mammalian G protein subunits, including Gα s , Gα o (Mendel et al., 1995; Ségalat et al., 1995) , Gα q (Brundage et al., 1996) and Gβ (Zwaal et al., 1996) , which allows detailed genetic analysis of conserved G protein-coupled signal transduction pathways in a relatively simple organism.
We previously reported that gsa-1 encodes a conserved nematode Gα s subunit which is essential and is ubiquitously expressed in the nervous system and muscle cells of C.elegans (Korswagen et al., 1997) . A constitutively activating mutation in Gα s that inhibits the GTPase activity of the protein and locks it in the GTP-bound active conformation, induces body-wall muscle hypercontraction and swelling, and vacuolization of a specific subset of neurons. Neurons which are susceptible to activated Gα sinduced degeneration are mainly ventral nerve cord motoneurons and some neurons located in the head and tail ganglia. This neuronal cell death is distinct from programmed cell death and is similar in morphology to the neuronal degeneration observed in degenerin mutants of C.elegans (Chalfie and Wolinsky, 1990; Driscoll and Chalfie, 1991; Hall et al., 1997) . The degenerins deg-1 and mec-4 encode proteins which are similar to subunits of mammalian amiloride-sensitive Na ϩ channels and form mechanosensory channels in C.elegans (Hong and Driscoll, 1994; Huang and Chalfie, 1994) , whereas deg-3 encodes an acetylcholine receptor channel-subunit (Treinin and Chalfie, 1995) . The degeneration-inducing mutations in deg-1, deg-3 and mec-4 presumably hyperactivate these channels, resulting in an increased or altered ion-influx that is followed by cell death. The morphological similarity of activated Gα s -induced neuronal degeneration to degenerin-induced cell death suggests that Gα s directly or indirectly hyperactivates ion-channels. This might be a direct interaction of Gα s with ion-channels (reviewed in Wickman and Clapham, 1995) , or could be indirect through, for example, the activation of an adenylyl cyclase, resulting in generation of the second messenger cyclic-3Ј,5Ј-adenosine monophosphate (cAMP) (reviewed in Sunahara et al., 1996) . Increased levels of cAMP can directly modulate cAMP-gated ion-channels or modulate ion channels through activation of cAMP-dependent protein kinase A (PKA) (reviewed in Walsh and Van Patten, 1994; Wickman and Clapham, 1995) .
To study the mechanism of activated Gα s -induced neuronal degeneration, we characterized extragenic suppressors which inhibit neuronal cell death (Korswagen et al., 1997) . Here we show that one of these suppressors, sgs-1, encodes an adenylyl cyclase that is essential for activated Gα s -induced neurotoxicity. Furthermore, we studied a second adenylyl cyclase gene (acy-2) of C.elegans. We show that acy-2 is expressed in the canalassociated neurons (CAN) and that loss of acy-2 results in a larval lethal phenotype which is similar to the lethal phenotype of gsa-1 null mutant animals.
Results

sgs-1 is a suppressor of activated Gα s -induced neuronal degeneration
In a screen for extragenic suppressors of activated Gα sinduced neuronal degeneration, a locus was identified that suppresses neuronal cell death. This locus was named sgs-1 (suppressor of activated Gs; Korswagen et al., 1997) . Tc1 insertion 0 ϩϩ a Activated Gα s -induced pattern of neuronal cell deaths as described in Korswagen et al. (1997) . Phenotypes were scored in synchronized L1-2 larvae, 24 h after a 2 h heat-shock at 33°C. b Animals showing a Dpy appearance and strong folding of the intestine were scored as positive for body-wall muscle hypercontraction (-, 0-10%; ϩ, 5-25%; ϩϩ, 25-50%; ϩϩϩ, 50-75%; ϩϩϩϩ, Ͼ75% of animals that show body-wall muscle hypercontraction). c sgs-1 alleles were analyzed in an activated Gα s (pkIs296) background
As is shown in Table I , each of eight alleles of sgs-1 completely suppress neuronal degeneration. In contrast to the complete suppression of neuronal cell death, suppression of the activated Gα s -induced body-wall muscle hypercontraction is variable. Animals mutant in sgs-1 do not show obvious defects in development or behavior. A deletion that spans the sgs-1 locus was used to determine whether mutant phenotypes associated with sgs-1 could be uncovered by lowering the level of sgs-1 by half. When sgs-1(pk310) and sgs-1(pk450::Tc1) were placed in trans to the genetic deficiency sDf121, which deletes the sgs-1 locus (D.Baillie, personal communication), the heterozygous animals did not show any changes in development or behavior. These results suggest that sgs-1 is not an essential gene.
sgs-1 encodes an adenylyl cyclase sgs-1 was placed on linkage group III, to the left of the deficiency nDf17, between markers unc-93 and unc-32, and was found to be closely linked to dpy-17 ( Figure 1A ). The area of the physical map of chromosome III that corresponds to this region is completely sequenced (Wilson et al., 1994) and cosmids containing candidate genes were tested for rescue of the Sgs phenotype. Cosmid F17C8 rescued sgs-1, resulting in the reappearance of swollen and vacuolized neurons after expression of activated Gα s . Unrelated cosmids did not rescue sgs-1. Rescue of sgs-1 was also obtained with a subclone of F17C8 ( Figure 1B ). This 14 kb subclone contains a single predicted gene that encodes a 1254 amino acid protein ( Figure 2A ) with significant sequence similarity to mammalian adenylyl cyclases. As is shown in Figure 3 , SGS-1 is most similar (39% overall identity, 48% similarity of amino acid positions) to mouse adenylyl cyclase type IX. Sequence similarity is highest in the conserved C1a and C2a regions of the two catalytic domains of adenylyl cyclase, with 67 and 60% identity of amino acid positions, respectively, between SGS-1 and mouse adenylyl cyclase type IX. The predicted protein shows the characteristic topology of a membrane localized adenylyl cyclase, which consists of a short intracellular N-terminal sequence, two multiple transmembrane spanning regions and two large intracellular catalytic domains ( Figure 2B ).
Mutations in sgs-1 change conserved residues in the adenylyl cyclase coding sequence
The coding sequence of sgs-1 was scanned for mutations in different alleles that suppress neuronal cell death. All mutations found were G-A or C-T substitutions, which correspond to the canonical mutation spectrum of ethyl methanesulfonate (EMS) (Anderson, 1995) , the mutagen used in the genetic screens to isolate alleles of sgs-1 (Korswagen et al., 1997) . With the exception of mutations in pk310 and pk393, only mutations were found that change amino acid positions which are conserved between different adenylyl cyclases ( Figure 2A ); in pk310 no mutational change could be detected in the sgs-1 coding sequence, in pk393, a non-conserved Gly at position 68 is changed into an Arg. In pk363, a conserved Gly at position 199 in the first region of transmembrane domains is changed into a Glu. Two mutations are in the catalytic domains. In pk301 a Ser at position 486 in the first catalytic domain is changed into a Tyr, in pk384 a Gly at position 1068 in the second catalytic domain is changed into an Arg. Two independent alleles of sgs-1 (pk311 and pk474) contain an identical splice donor site mutation located in the first catalytic domain that changes the canonical GT splice donor sequence to AT. Sequencing of pk311 sgs-1 cDNA revealed that cryptic splice donor sites surrounding the mutated splice donor are used, some of which may retain the correct reading frame (data not shown).
The isolation of an identical mutational change in the independent alleles pk311 and pk474 implies that only a limited spectrum of mutations are tolerated in sgs-1. To address whether only specific mutational changes in sgs-1 can result in suppression of neuronal cell death, or whether any loss-of-function mutation in sgs-1 can produce this phenotype, a Tc1 transposon insertion located in the sgs-1 coding sequence (Figure 2A ) was isolated from a library of random Tc1 insertion mutants (Zwaal et al., 1993) . Insertion of Tc1 can disrupt a gene by truncation of the coding sequence or can affect the protein product by cryptic splicing of the transcript (Rushforth et al., 1993) . As is shown in Table I , the sgs-1 transposon allele pk450::Tc1 completely suppresses activated Gα s -induced neuronal degeneration, demonstrating that a randomly isolated presumed loss-of-function allele of sgs-1 suppresses neuronal cell death as well. Furthermore, these results suggest that loss of sgs-1 function does not result in severe developmental or behavioral phenotypes.
sgs-1 is expressed in the nervous system
Presumptive upstream control sequence of sgs-1 was used to direct expression of a Green Fluorescent Protein (GFP) encoding reporter gene. The gfp reporter gene was inserted close to the 3Ј end of sgs-1 and the fusion construct includes all intron sequences of sgs-1 (Figure 2A ). Since this fusion contains almost the complete sgs-1 gene, it is likely that this fusion closely sgs-1 encodes an adenylyl cyclase resembles the endogenous sgs-1 expression pattern. sgs-1::gfp shows a general neuronal expression pattern, with expression in neurons of the head ganglia ( Figure 4A ), the ventral nerve cord ( Figure 4B and C) and the tail ganglia ( Figure 4C ). Not all neurons express the sgs-1 reporter; expression is faint or absent in the CAN cells and is less extensive in the anterior head ganglion. sgs-1 is also expressed in the muscle cells of the vulva ( Figure 4B ) and in adult animals at low levels in bodywall muscle cells. Based on this reporter construct, sgs-1 is not expressed in the muscle cells of the pharynx, nor is sgs-1 expressed in hypodermal or intestinal cells.
acy-2 encodes a second C.elegans adenylyl cyclase
The identification of sgs-1 as an adenylyl cyclase, prompted us to search the C.elegans genome database for additional adenylyl cyclase genes. A gene encoding a second predicted adenylyl cyclase was identified by the C.elegans genome project (C.elegans genome consortium, unpublished observation). C10F3.3 encodes a predicted protein (ACY-2) of 1080 amino acids which shows significant sequence similarity to mammalian adenylyl cyclases (35% overall identity, 45% similarity to adenylyl cyclase type II; Figure 3 ). Like SGS-1, ACY-2 contains the highly conserved C1a and C2a sequences (64% and 80% identity to adenylyl cyclase type II, respectively), and shows the expected structural organization of two multiple transmembrane regions and two large intracellular catalytic domains ( Figure 2B ). acy-2 shows a more limited expression pattern than sgs-1. A translational fusion of acy-2 to gfp is expressed at high levels in the CAN cells ( Figure 4E ) and some neurons in the head ganglia ( Figure 4D ), and at low levels in a small number of ventral nerve cord neurons. We isolated a deletion of acy-2 genomic sequence from a library of chemically-induced deletion mutants (Jansen et al., 1997) . In acy-2 (pk465), a 2.7 kb region of the acy-2 sequence is deleted, removing the first catalytic domain and the two multiple transmembrane regions ( Figure 1C ). Loss of acy-2 results in early larval lethality; animals homozygous for pk465 arrest at the first stage of larval development ( Figure 4F ), a phenotype that is similar to the larval lethal null phenotype of gsa-1 (Korswagen et al., 1997) . This lethal phenotype was rescued by introduction of the acy-2(ϩ) containing cosmid C10F3 in pk465 animals. Interestingly, rescued pk465 lines segregated animals that appeared fluid filled, a phenotype that is reminiscent of clr-1 mutants and suggests a defect in the CAN cells. The CAN cells have a function in osmoregulation (Forrester and Garriga, 1997) . Taken together, these results suggest that Gα s and ACY-2 perform an essential function in the CAN cells.
Discussion
Adenylyl cyclases are a family of signaling molecules that generate the second messenger cAMP. Mammals express at least nine different adenylyl cyclase isoforms which are all stimulated by Gα s and the diterpene forskolin, but differ otherwise in stimulation or inhibition by other Gα subunits, Gβγ, Ca 2ϩ -calmodulin and protein kinase C (PKC) (reviewed in Sunahara et al., 1996) . Since adenylyl cyclases are modulated by components of different signal transduction pathways, they constitute an important level of integration of diverse signals. Some isoforms of adenylyl cyclase require, for instance, stimulatory input from both Gα s and Ca 2ϩ -calmodulin and function as coincidence detectors. An example of an adenylyl cyclase acting as such a coincidence detector is provided by the Drosophila Rutabaga gene (Levin et al., 1992) , which plays a role in associative learning and memory storage (reviewed in Kandel and Abel, 1995) . Adenylyl cyclases are transmembrane proteins that consist of a short, nonconserved intracellular N-terminal sequence, a region of six transmembrane regions followed by a large intracellular (Kyte and Doolittle, 1982) showing the multiple transmembrane regions in SGS-1 and ACY-2. catalytic domain (C1) and a second region of six transmembrane domains followed by a second intracellular catalytic domain (C2). The two catalytic domains each contain a 5062 Fig. 3 . Alignment dendogram generated using the PILEUP algorithm using default program parameters. SGS-1 is most closely related to mouse adenylyl cyclase type IX.
highly conserved region (C1a and C2a, respectively) which is similar between the two catalytic domains. In stimulated adenylyl cyclase, the two catalytic domains come together to form a catalytically active heterodimer (Zhang et al., 1997) .
As in mammals, multiple isoforms of adenylyl cyclases are present in C.elegans; in addition to sgs-1 and acy-2, the C.elegans genome contains at least a third gene that encodes a predicted adenylyl cyclase (C.elegans genome consortium, unpublished observation). Study of such conserved signaling molecules in C.elegans offers the advantage of a well defined system and allows detailed genetic analysis of adenylyl cyclase function in the nematode. Here we describe two C.elegans adenylyl cyclases, SGS-1 and ACY-2. SGS-1 was identified as a suppressor of activated Gα s -induced neuronal cell death, ACY-2 was identified by the C.elegans genome project. Both SGS-1 and ACY-2 show significant sequence similarity to mammalian adenylyl cyclases, with highest sequence homology within the C1a and C2a domains. In addition, both predicted proteins show the expected multiple transmembrane regions and large cytoplasmatic domains characteristic of adenylyl cyclases. With the exception of SGS-1, which has a Ser at the position of a conserved Lys in C1a, both proteins contain the Lys and Asp residues in the C1a and C2a regions that confer specificity to adenosine triphosphate as opposed to guanosine triphosphate in the related family of guanylyl cyclases . Of mammalian adenylyl cyclases, SGS-1 is most similar to mouse adenylyl cyclase type IX, a divergent class of adenylyl cyclases (Premont et al., 1996) . Type IX adenylyl cyclase is abundantly expressed, with highest levels in skeletal muscle and brain. Interestingly, type IX adenylyl cyclase is relatively insensitive to forskolin and does not seem to be modulated by Gβγ or Ca 2ϩ . It is not known however, whether this is also the case for SGS-1.
Different loss-of-function alleles of sgs-1 show a range of mutations in the sgs-1 coding sequence. All single amino acid substitutions change small non-charged residues such as Gly and Ser into large, highly charged residues such as Arg and Glu or large aromatic residues such as Tyrmutations which may affect the catalytic action of the protein or may result in a conformational change. Two mutations are located within the C1a domain. In pk301, a highly conserved Ser is changed into a Tyr, whereas in pk311 and pk474 a splice donor site is disrupted, a change that will affect the C1a sequence as well. Given the importance of the C1a region for the catalytic activity of adenylyl cyclases, it is likely that these mutations directly influence SGS-1 activity. One mutation (pk384) is at the border of the C2a domain, three positions upstream of a sequence which is part of a negatively charged hydrophobic groove that is an important binding region for Gα s (Tesmer et al., 1997; Yan et al., 1997) . Introduction of a positively charged Arg close to this domain may interfere with Gα s binding and uncouple SGS-1 from activation by Gα s . Two further mutations are within the first multiple transmembrane region of SGS-1. These mutations may not affect SGS-1 activity directly, but may interfere with sorting and localization of SGS-1, as has been shown for mutations in the first multiple transmembrane region of the Dictyostelium adenylyl cyclase ACA (Parent and Devreotes, 1995) .
No mutations were found that result in early termination or frame-shift of the SGS-1 protein. Therefore, it is not clear whether any of the mutations described represents a complete loss-of-function allele of sgs-1. A putative null allele of sgs-1 was however isolated from a library of Tc1 insertion mutants. Insertion of Tc1 may lead to truncation of the SGS-1 protein sequence or will affect the sgs-1 protein product through cryptic splicing (Rushforth et al., 1993) . Truncation at this insertion site will remove the complete C2 region, which is essential for adenylyl cyclase activity.
Mutation of sgs-1 does not result in severe developmental or behavioral phenotypes. This is in contrast to acy-2, mutation which results in larval lethality. This lethal phenotype is similar to the larval lethal phenotype of gsa-1 null mutant animals (Korswagen et al., 1997) . The clr-1-like appearance of incompletely rescued acy-2 (pk465) animals suggests a defect in the CAN cells (Forrester and Garriga, 1997) , a phenotype that is in agreement with the expression of acy-2 in these cells. Therefore, it is likely that Gα s and ACY-2 perform an essential function in the CAN cells, whereas SGS-1 has a more subtle, but non-redundant function. Reporter fusions of sgs-1 show a general expression in the nervous system, including neurons in the head ganglia, the ventral nerve cord and the tail ganglia. Consequently, sgs-1 is expressed in the neurons that are susceptible to activated Gα s -induced cell death. Mutation of sgs-1 also influences activated Gα s -induced body-wall muscle hypercontraction. It is not known whether this is a direct result of sgs-1 function in muscle cells, or is the result of a function of sgs-1 in motoneurons.
At least one other locus (sgs-2; H.Korswagen, unpublished observation) was identified that can be mutated to suppress activated Gα s -induced neuronal degeneration. Cloning of additional loci will uncover more components of Gα s -coupled signal transduction in C.elegans and may elucidate the mechanism with which overactivity of Gα s and SGS-1 induces neurotoxicity.
Materials and methods
Nematode strains and culturing
General methods for culture, manipulation and genetics of C.elegans were as described (Lewis and Fleming, 1995) . Strains used in this study were Bristol N2, NL545 (dpy-20(e1362)IV; pkIs296 ]X), MT690 (unc-93(e1500) dpy-17(e164)III), SP471 (dpy-17-(e164) unc-32(e189)III), MT1169 (nDf17/dpy-17(e164)tra-1(e1099)III) and BC4697 (sDp3(III;f); sDf121(s2098) unc-32(e189)III). All sgs-1 mutations were generated in an NL545 background as described (Korswagen et al., 1997) . sgs-1 alleles pk363, pk384, pk393 and pk474 were isolated in this study. A Tc1 insertion in sgs-1 (pk450::Tc1) was isolated from a library of Tc1 insertion mutants using primers seq13 GATAGTGGTCACTGGTTG and seq15 GTTGTTCCAATGACACCA-GC, as described (Zwaal et al., 1993) . A deletion mutant of acy-2 (pk465) was isolated from a chemical deletion library using primers del5, AATGTCTCATTCCCGCTC; del8, CAGCAACACTCGAAGGT-AAG and nested primers del6, GCAAAACTTACCGATGTGCTCC and del7, TAGTTTCCACGTCACGTTCCTC as described (Jansen et al., 1997) .
Positional cloning of sgs-1 sgs-1 was placed on linkage group III ( Figure 1A) (Korswagen et al., 1997) . Using further three-factor crosses with a dpy-17unc-32 marked chromosome, sgs-1 was placed to the left or close to dpy-17 (16/16 were SgsUnc, 0/11 were SgsDpy). Crosses with an unc-93dpy-17 marked strain established that sgs-1 maps to the right of unc-93 and close to dpy-17 (10/10 were SgsUnc, 0/3 were SgsDpy). Furthermore, the deficiency nDf17 does not uncover sgs-1 (in 15/15 crosses, sgs-1(pk310)/ nDf17; pkIs296/ϩ animals showed neuronal degeneration after expression of activated Gα s ). A cosmid containing a putative adenylyl cyclase gene from this region was tested for rescuing activity. Cosmid F17C8 was injected at a concentration of 10 μg/ml with the rol-6(su1006) marker plasmid pRF4 (Kramer et al., 1990) in NL586 (sgs-1(pk310); dpy-20(e1362); pkIs296 ] (Mello and Fire, 1995) . Animals were analyzed for neuronal degeneration after expression of activated Gα s as described (Korswagen et al., 1997) . Cosmids T20G5 and F54G8 did not rescue sgs-1. pRP1522, a 14 kb SpeI/XhoI fragment containing the adenylyl cyclase gene, was subcloned from F17C8 ( Figure 1B) . The GENEFINDER prediction of the sgs-1 (and acy-2) coding sequence, as annotated in the C.elegans database ACeDB (Eeckman and Durbin, 1995) , was confirmed by sequencing of random and oligo-dT primed cDNA amplified by reverse transcriptase PCR. These sequence data have been submitted by the C.elegans genome consortium to the DDBJ/ EMBL/GenBank databases under accession No. Z35719 for SGS-1 and AF022968 for ACY-2. The open reading frame of sgs-1 was scanned for mutations in different sgs-1 alleles by sequence analysis of genomic DNA.
Sequence analysis of SGS-1 and ACY-2
Multiple alignments of SGS-1 and mammalian and Drosophila adenylyl cyclase sequences (Swiss-Prot accession Nos P51830, P26769, P26770, P51829, Q04400, Q01341, P19754, P97490 and P21932) were made using the Genetics Computer Group (version 9.1) PILEUP program (Genetics Computer Group Inc., Wisconsin). A Kyte-Doolittle hydrophobicity plot (Kyte and Doolittle, 1982) was made using the Genetics Computer Group PEPPLOT program.
GFP reporter constructs
A fusion of gfp close to the predicted 3Ј end of sgs-1 (pRP1523) was constructed by cloning an XbaI/ApaI fragment of pPD95.77 (A.Fire, personal communication) in unique NheI and ApaI sites of pRP1522. pRP1523 was injected at 50 μg/ml (plus 50 μg/ml pMH86 and 100 μg/ml pBluescript) in CB1362 [dpy-20(e1362)IV] (Han and Sternberg, 1991) . The transgenic array was integrated by irradiating animals with 40 Gy of gamma radiation from a 137 Cs source (Way et al., 1991) . A fusion of gfp to acy-2 was constructed by cloning an 8.7 kb PstI/SpeI fragment of C10F3 in the PstI and XbaI sites of pPD95.77 ( Figure 1C ). pRP1525 was injected at a concentration of 100 μg/ml with 100 μg/ml pRF4 in Bristol N2 animals. Cells were identified in reference to Sulston and Horvitz (1977) and White et al. (1986) .
